Space SHOCK: NASA ISS study suggests ‘unknown risks’ of long duration space missions

The astronaut, guided in real time and interpreted by two independent radiologists on earth, performed a follow-up ultrasound, which confirmed the diagnosis.

Since NASA had not encountered this condition in space before, multiple speciality discussions weighed the unknown risks of the clot traveling and blocking a vessel against anticoagulation therapy in microgravity.

Although the ISS pharmacy had 20 vials of the injectable blood thinner enoxaparin, there was no anticoagulation-reversal drug.

The injections posed their own challenges—syringes are a limited commodity, while drawing liquids from vials is notoriously difficult because of surface-tension effects.

DON’T MISS

Asteroid danger: 100% certainty of impact warns space expert [INTERVIEW]
Hubble snaps galaxy ‘like a portal to another dimension’ [PICTURES]
What is the mysterious dark vortex NASA found on Neptune? [ANALYSIS]